Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Progesterone (exclusively Dosage Form Vka), Atc G03da04 For The Period 03/01/2023 - 02/28/20

DAK-GESUNDHEIT Germany has Released a tender for Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Progesterone (exclusively Dosage Form Vka), Atc G03da04 For The Period 03/01/2023 - 02/28/20 in Pharmaceuticals. The tender was released on Jan 21, 2023.

Country - Germany

Summary - Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Progesterone (exclusively Dosage Form Vka), Atc G03da04 For The Period 03/01/2023 - 02/28/20

Deadline - Jan 05, 2025

MT reference number - 11279498

Product classification - Medical solutions

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 11279498

  Document Type - Tender Notices

Notice Details and Documents:

Description - Contract notice: Conclusion of a non-exclusive discount agreement according to § 130a para. 8 sgb v on the active ingredient progesterone (exclusively dosage form vka), atc g03da04 for the period 03/01/2023 - 02/28/2025§ 130a paragraph 8 sgb v enab les the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be dispensed at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures takes place according to the regulations of the 4th part of the GWB by the dak health. for medicinal p

Mt Ref Id - 11279498

Deadline - Jan 05, 2025

Share

Similar Tenders :